Archna Bajaj

1.2k total citations · 1 hit paper
32 papers, 810 citations indexed

About

Archna Bajaj is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Archna Bajaj has authored 32 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 8 papers in Cardiology and Cardiovascular Medicine and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Archna Bajaj's work include Lipoproteins and Cardiovascular Health (15 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Lipid metabolism and disorders (5 papers). Archna Bajaj is often cited by papers focused on Lipoproteins and Cardiovascular Health (15 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Lipid metabolism and disorders (5 papers). Archna Bajaj collaborates with scholars based in United States, Australia and Austria. Archna Bajaj's co-authors include Eva Schernhammer, Jane A. Driver, Steven W. Lockley, Daniel Soffer, Pam R. Taub, Michael J. Wilkinson, Daniel J. Rader, Susan E. Hankinson, Elizabeth E. Devore and Mariana G. Figueiro and has published in prestigious journals such as Circulation, Nature Medicine and Journal of the American College of Cardiology.

In The Last Decade

Archna Bajaj

28 papers receiving 797 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice

2024 127 citations Marlys L. Koschinsky, Archna Bajaj et al. Journal of clinical lipidology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Archna Bajaj United States	14	277	163	143	118	116	32	810
Qin Luo China	21	173 0.6×	271 1.7×	394 2.8×	301 2.6×	171 1.5×	94	1.6k
Paul H. Berg United States	15	178 0.6×	109 0.7×	177 1.2×	131 1.1×	49 0.4×	30	1.1k
Dennis Heutling Germany	9	251 0.9×	161 1.0×	129 0.9×	251 2.1×	19 0.2×	17	1.2k
Jingtao Dou China	20	310 1.1×	799 4.9×	292 2.0×	266 2.3×	54 0.5×	94	1.4k
Thomas Guttuso United States	17	119 0.4×	572 3.5×	51 0.4×	32 0.3×	141 1.2×	35	1.2k
Masashi Yoshida Japan	16	407 1.5×	321 2.0×	296 2.1×	113 1.0×	14 0.1×	29	955
Takayuki Ishida Japan	16	100 0.4×	62 0.4×	150 1.0×	60 0.5×	54 0.5×	63	631
Nancy L. Heard‐Costa United States	18	92 0.3×	106 0.7×	371 2.6×	173 1.5×	97 0.8×	37	1.2k
Kristy L. Jackson Australia	18	99 0.4×	146 0.9×	181 1.3×	215 1.8×	12 0.1×	57	787
Georgi Кirilov Bulgaria	20	192 0.7×	471 2.9×	117 0.8×	79 0.7×	16 0.1×	69	1.1k

Countries citing papers authored by Archna Bajaj

Since Specialization

Citations

This map shows the geographic impact of Archna Bajaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Archna Bajaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Archna Bajaj more than expected).

Fields of papers citing papers by Archna Bajaj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Archna Bajaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Archna Bajaj. The network helps show where Archna Bajaj may publish in the future.

Co-authorship network of co-authors of Archna Bajaj

This figure shows the co-authorship network connecting the top 25 collaborators of Archna Bajaj. A scholar is included among the top collaborators of Archna Bajaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Archna Bajaj. Archna Bajaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bajaj, Archna, Elif A Oral, Alan S. Brown, et al.. (2025). Clinical considerations for the treatment of patients with familial chylomicronemia syndrome using a hepatic-targeted APOC3 antisense oligonucleotide. American Journal of Preventive Cardiology. 24. 101352–101352.

Bajaj, Archna & Daniel J. Rader. (2025). Targeting triglyceride-rich lipoproteins in cardiovascular disease. Nature Medicine. 31(8). 2492–2493.

Bhatia, Harpreet, Archna Bajaj, Sascha N. Goonewardena, & Patrick M. Moriarty. (2025). Pelacarsen: Mechanism of action and Lp(a)-lowering effect. Journal of clinical lipidology. 19(5). 1208–1222. 1 indexed citations

Bajaj, Archna, et al.. (2024). ASCVD Risk Reduction in Patients with Immune-Mediated Inflammatory Disease: A Retrospective Quality Assessment Study. Journal of clinical lipidology. 18(4). e510–e511. 1 indexed citations

Bajaj, Archna, et al.. (2024). Real-world experience of inclisiran prescription at the University of Pennsylvania Health Systems. Journal of clinical lipidology. 18(6). e1096–e1100. 3 indexed citations

Soffer, Daniel, et al.. (2024). Attitudes and barriers to lipoprotein(a) testing: A survey of providers at the University of Pennsylvania Health System. Journal of clinical lipidology. 18(5). e873–e876. 6 indexed citations

Wilkinson, Michael J., Archna Bajaj, Margaret E. Brousseau, & Pam R. Taub. (2024). Harnessing RNA Interference for Cholesterol Lowering: The Bench‐to‐Bedside Story of Inclisiran. Journal of the American Heart Association. 13(6). e032031–e032031. 18 indexed citations

Koschinsky, Marlys L., Archna Bajaj, Michael B. Boffa, et al.. (2024). A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. Journal of clinical lipidology. 18(3). e308–e319. 127 indexed citations breakdown →

Bajaj, Archna, et al.. (2024). Attitudes and Barriers to Lipoprotein(a) Testing: A Survey of Providers at the University of Pennsylvania Health System. Journal of clinical lipidology. 18(4). e487–e488. 3 indexed citations

10.

Fanaroff, Alexander C., Rim Halaby, Monika Sanghavi, et al.. (2023). Feasibility and outcomes from using a commitment device and text message reminders to increase adherence to time-restricted eating: A randomized trial. American Heart Journal. 258. 85–95. 6 indexed citations

11.

Bajaj, Archna, et al.. (2023). Establishing a patient‐centered, multidisciplinary pharmacogenomics clinic in an academic health system: Successes, challenges, and future direction. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 7(3). 234–243. 1 indexed citations

12.

Rosenson, Robert S., Shia T. Kent, Vera Bittner, et al.. (2023). Lipoprotein(a) and the Risk for Recurrent Atherosclerotic Cardiovascular Events Among Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Kidney Medicine. 5(7). 100648–100648. 4 indexed citations

13.

Lan, N., Archna Bajaj, Gerald F. Watts, & Marina Cuchel. (2023). Recent advances in the management and implementation of care for familial hypercholesterolaemia. Pharmacological Research. 194. 106857–106857. 9 indexed citations

14.

Rosenson, Robert S., Shia T. Kent, Vera Bittner, et al.. (2022). LIPOPROTEIN(A) AND THE RISK FOR ATHEROSCLEROTIC CARDIOVASCULAR EVENTS AMONG ADULTS WITH CHRONIC KIDNEY DISEASE AND A HISTORY OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE. Journal of the American College of Cardiology. 79(9). 1511–1511. 3 indexed citations

15.

Hernández, Patricia, et al.. (2021). Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis. Current Atherosclerosis Reports. 23(11). 72–72. 37 indexed citations

16.

Bajaj, Archna, Chengxiang Qiu, Aeron Small, et al.. (2020). Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways. Kidney International. 97(5). 1032–1041. 17 indexed citations

17.

Bajaj, Archna & Marina Cuchel. (2020). Homozygous familial hypercholesterolemia: what treatments are on the horizon?. Current Opinion in Lipidology. 31(3). 119–124. 11 indexed citations

18.

Bajaj, Archna, Dawei Xie, Jeanne Charleston, et al.. (2019). Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD. American Journal of Kidney Diseases. 73(6). 827–836. 53 indexed citations

19.

Bajaj, Archna & Daniel J. Rader. (2017). Can changes in the plasma lipidome help explain the cardiovascular benefits of the Mediterranean diet?. American Journal of Clinical Nutrition. 106(4). 965–966. 1 indexed citations

20.

Bajaj, Archna, Bernard Rosner, Steven W. Lockley, & Eva Schernhammer. (2011). Validation of a Light Questionnaire with Real-life Photopic Illuminance Measurements: the Harvard Light Exposure Assessment Questionnaire. Cancer Epidemiology Biomarkers & Prevention. 20(7). 1341–1349. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact